{"id":{"repo_id":"erasmus","oai_identifier":"oai:repub.eur.nl:98975"},"canonical_url":"https://search.dev.ndltd.org/etd/erasmus/oai:repub.eur.nl:98975","repository":{"repo_id":"erasmus","name":"Erasmus University Rotterdam","base_url":"https://repub.eur.nl/oai"},"display":{"title":"The impact of HPV vaccination on HPV and cervical cancer in the Netherlands","abstract":"Human papillomavirus (HPV) is a highly prevalent sexually transmitted virus, of which 150 types have been completely sequenced. Currently, about 14 HPV-types are considered ‘high risk’ for their potential to cause cervical cancer, the fourth most common cancer among women worldwide. In particular HPV-16 and HPV-18 are predominantly present in precancerous lesions and invasive cervical cancer. Luckily, vaccines have been developed to protect against these HPV-types. This thesis includes modeling studies in which we explore the role of naturally acquired immunity after clearing an HPV-16 and HPV-18 infection in the spread of HPV, as well as the impact of HPV vaccination on HPV and cervical cancer in the Netherlands.","abstract_html":"Human papillomavirus (HPV) is a highly prevalent sexually transmitted virus, of which 150 types have been completely sequenced. Currently, about 14 HPV-types are considered ‘high risk’ for their potential to cause cervical cancer, the fourth most common cancer among women worldwide. In particular HPV-16 and HPV-18 are predominantly present in precancerous lesions and invasive cervical cancer. Luckily, vaccines have been developed to protect against these HPV-types. This thesis includes modeling studies in which we explore the role of naturally acquired immunity after clearing an HPV-16 and HPV-18 infection in the spread of HPV, as well as the impact of HPV vaccination on HPV and cervical cancer in the Netherlands.","abstract_has_math":false,"creators":["Matthijsse Suzette"],"institution":"Erasmus University Rotterdam","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-05-03","date_published":"2017-05-03","updated_at":"2026-07-27T19:26:41Z","subjects":["Human papillomavirus","HPV","cervical cancer","vaccination","screening","mathematical modeling","microsimulation"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1765/98975","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.issued","label":"Date","values":["2017-05-03"]},{"key":"dc:publisher","label":"Institution","values":["Erasmus University Rotterdam"]},{"key":"dc:type","label":"Dc Type","values":["dissertation"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Human papillomavirus","HPV","cervical cancer","vaccination","screening","mathematical modeling","microsimulation"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1765/98975","https://repub.eur.nl/pub/98975/170503_Matthijsse-Suzetta-Maria.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.other","label":"Dc Description Other","values":["Human papillomavirus (HPV) is a highly prevalent sexually transmitted virus, of which 150 types have been completely sequenced. Currently, about 14 HPV-types are considered ‘high risk’ for their potential to cause cervical cancer, the fourth most common cancer among women worldwide. In particular HPV-16 and HPV-18 are predominantly present in precancerous lesions and invasive cervical cancer. Luckily, vaccines have been developed to protect against these HPV-types. This thesis includes modeling studies in which we explore the role of naturally acquired immunity after clearing an HPV-16 and HPV-18 infection in the spread of HPV, as well as the impact of HPV vaccination on HPV and cervical cancer in the Netherlands."]},{"key":"dc:title","label":"Title","values":["The impact of HPV vaccination on HPV and cervical cancer in the Netherlands"]}]}],"canonical_facts":{"dc:date.issued":["2017-05-03"],"dc:description.other":["Human papillomavirus (HPV) is a highly prevalent sexually transmitted virus, of which 150 types have been completely sequenced. Currently, about 14 HPV-types are considered ‘high risk’ for their potential to cause cervical cancer, the fourth most common cancer among women worldwide. In particular HPV-16 and HPV-18 are predominantly present in precancerous lesions and invasive cervical cancer. Luckily, vaccines have been developed to protect against these HPV-types. This thesis includes modeling studies in which we explore the role of naturally acquired immunity after clearing an HPV-16 and HPV-18 infection in the spread of HPV, as well as the impact of HPV vaccination on HPV and cervical cancer in the Netherlands."],"dc:identifier.uri":["http://hdl.handle.net/1765/98975","https://repub.eur.nl/pub/98975/170503_Matthijsse-Suzetta-Maria.pdf"],"dc:publisher":["Erasmus University Rotterdam"],"dc:subject":["Human papillomavirus","HPV","cervical cancer","vaccination","screening","mathematical modeling","microsimulation"],"dc:title":["The impact of HPV vaccination on HPV and cervical cancer in the Netherlands"],"dc:type":["dissertation"]},"updated_at":"2026-07-27T19:26:41Z"}